Stonepine Capital Management’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8M Buy
3,349,627
+47,327
+1% +$229K 7.22% 1
2026
Q1
$17.5M Buy
3,302,300
+570,221
+21% +$3.52M 7.01% 3
2025
Q4
$21.1M Buy
2,732,079
+62,047
+2% +$553K 15.4% 1
2025
Q3
$23.6M Buy
2,670,032
+1,309,646
+96% +$9.75M 19.17% 1
2025
Q2
$5.65M Buy
1,360,386
+747,386
+122% +$4.68M 5.54% 4
2025
Q1
$3.7M Sell
613,000
-257,000
-30% -$1.57M 3.6% 5
2024
Q4
$4.5M Sell
870,000
-440,287
-34% -$1.73M 3.63% 6
2024
Q3
$3.92M Buy
+1,310,287
New +$3.56M 2.48% 12
2019
Q2
Sell
-41,667
Closed -$1.48M 29
2019
Q1
$1.48M Buy
+41,667
New +$1.65M 0.85% 25
2018
Q1
Sell
-18,750
Closed -$691K 34
2017
Q4
$691K Buy
+18,750
New +$847K 0.41% 24

Other funds holding VSTM

Stonepine Capital Management's VSTM Position: Q2 2026 in Review

Stonepine Capital Management increased its Verastem (VSTM) stake by 1.4% in Q2 2026, buying an estimated $229K and bringing the position to 3,349,627 shares worth $12.8M. The position accounts for 7.22% of the portfolio, ranked #1.

Stonepine Capital Management first reported a position in VSTM in Q4 2017 and has held it in 10 quarters since. The position peaked at $23.6M in Q3 2025. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Stonepine Capital Management held 3,349,627 shares of Verastem worth $12.8M as of Q2 2026.
  • Stonepine Capital Management bought 47,327 Verastem shares in Q2 2026, an estimated $229K.
  • Verastem made up 7.22% of Stonepine Capital Management's portfolio in Q2 2026, its #1 holding.
  • Stonepine Capital Management first reported a position in Verastem in Q4 2017 and has held it in 10 quarters since.
  • Stonepine Capital Management's Verastem position peaked at $23.6M in Q3 2025.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Stonepine Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.